RxDoctor Payments Data

Kaitlyn Carnwath

Adult Health · New Bern, NCNPI 1033629993

Payments from drug & device makers

$4,687in general payments, 2019–2025

Across 184 payments — averaging $25.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$585
  • E.r. Squibb & Sons, L.L.C.$523
  • AstraZeneca$280
  • Novartis$261
  • Johnson & Johnson$253
  • plus $974 from 12 others

What the payments were for

  • Travel & lodging$1,02622%
  • Food & beverage$3,51275%
  • Education$1493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,687 in reported general payments places this provider in the 90th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$97,047
Medicare patients
607
Services billed
1,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban242$241,120
XareltoRivaroxaban65$68,319
Dofetilide249$39,623
Flecainide Acetate168$4,535
Metoprolol Succinate174$2,848
SotalolSotalol Hcl136$1,958
Dilt-XrDiltiazem Hcl39$1,119
Diltiazem 24hr Er (Cd)Diltiazem Hcl60$875
Amiodarone Hcl74$705
Diltiazem Hcl42$599
Tiadylt ErDiltiazem Hcl16$556
Metoprolol Tartrate105$484
Valsartan22$291
Digoxin26$280
Losartan Potassium19$271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$34$241,120242 claims
Johnson & JohnsonXarelto$253$68,31965 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 adult health providers in North Carolina.

Other adult health in New Bern

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →